A new procedure for deli vering medication directly to the inne r ear has bee n deve lope d. Thi s deli very sys tem, called the MicroWickT M , invo lves the use of a small wick that is inse rted th rough a tympanic membrane vent tub e into the round window niche. Once the wick has been insert ed, the patient can self-adminis ter eardrops into the ear canal, whe re they are abso rbed by the wic k and transported to the round window membrane and to the inner ear fluids. Inserting the wick is a min or p rocedu re that is p erfo rmed in the office . This pap er describes the indicat ion sfo r an d use of the Mi croWick.
Introduction
Perfusion of the inner ear with various medic ation s such as gentamicin and steroids is becoming a more popul ar form of treatment for inner ear disease.':' There are three advantages to placing medications directly into the inner ear: 1) the physician can treat the diseased ear directl y without affecting the rest of the body; 2) systemic side effects of the drug are avoided ; and 3) a higher concentration of medication can be deli vered directly to the site. The current indications for the direct treatment of inner ear disease are for uncont rolled vertigo in Meniere' s disease, sudden viral deafness, and autoimmune inner ear disease.
Thr ee techniqu es have been developed thus far to inject medication directly into the inner ear. One route is through the tymp anic membrane into the middle ear.? Another route is through a tymp anostomy openin g onto Gelfo am that has been placed in the round window niche ."The third route is throu gh a microcath eter that has been inserted into the round window niche. ' The microcatheter technique is performed in the hospital, and both the catheter and the procedure are expensive.
A safer, simpler, and more cost-effective procedure for the treatment of inner ear disease has been develop ed. Thi s method involves the use of a small wick that is inserted throu gh a tymp anic membrane vent tube into the round window niche. The patient places eardrop s into the ear canal and they are absorbed by the wick and transported to the round window memb rane and to the inner ear fluids. The new device is called the MicroWick'>'. Inserting the wick is a minor procedure that can be perform ed in the office.
Insertion of the device
Anesthesia. Before inserting the MicroWick, the ear must be anesthetized. There are several ways to accomplish this. One way is to inject the ear with lidocaine I% and adrenaline (1:100,000) buffered with sodium bicarbonate (ratio: I ml of sodium bicarbon ate to 9 ml of lidocaine ). The bufferin g greatly dimini shes the initi al pain that is usually felt by the patient. Another method is to use drop s of a fresh mixture of 180 mg of topical tetracaine base powder with 0.2 ml of isopropyl alcohol. Thi s solution will anesthetize the tympanic memb rane in 10 minutes and will last for several hours.10.1 1 Finally, a third method is to apply phenol directly to the tymp anic membrane. But becau se topic al anesthetics do not numb the skin of the extern al auditory canal, infiltrative lidocaine and adrenaline are usually preferred when performing otoendoscop y. Tympanostomy and otoendoscopy, Befo re inserting the MicroWick, the surgeon may perform an otoendoscopy of the middle ear. The surgeon can use either a CO 2 laser to make a 2-mm bloodle ss openin g over the round window niche or a myringotom y knife to make a 4-mm incision parallel to the posterior canal wall at the level of the umbo . The round windo w lies appro ximately 3.44 mm (SD ± 0.68) posterior and inferior to the malleu s at a 113°( SD ± 9.9°) angle drawn from the tip of the umbo." In a normal tympanic membr ane, the round window is usually seen as a dark shadow beneath the t,Ympanic membrane.
A small 30°otoendoscope, 1.7 mm in diameter, is introduced to determine whether adhesions or membrane s are present over the round window memb rane that would obstruct or impede the flow of medication into the inne r ear; this occurs in approximately 20% of cases.' When such membranes are present, they are easily removed with a small pick. The adhe sions are approximately 1mm from the round window memb rane. Next, a silicone vent tube Silverstein with an inner diameter of 1.42 mm and a I-mm flan ge is inserted into the tymp anostomy opening. The round window niche is seen throu gh the tube opening (figure I) . The vent tube prevent s the swe lling caused by the MicroWi ck from enlarg ing the opening in the tymp ani c membrane.
Inserting the wick. The MicroWick is made of poly vinyl acetate. It is 9 mm long and I mm thick (figure 2), narro w enou gh to fit though a 1.42-mm vent tube. Before insertion, the wick should be rolled and compressed with gloved finger s to redu ce its diam eter. Wh en the target area is free of blood and fluid, the MicroWick is inserted Figure 2 . Pictur e of polyvinyl acetate Microvvick'". 596 through the vent tub e by placin g its distal end into the round window nich e (figures 3, 4).
After 4 weeks , the vent tube and the wick are remo ved with a pick as a single unit. Pull ing the wick throu gh the vent may cause it to break. The tympanostomy can be closed with a 3-mm 2 piece of Gelfilm impreg nated with an antibiotic ointment. The tympanic membrane usually heals in 2 to 4 weeks. Anesthesia is usuall y not necessary whe n removing a silicone vent tube or when placing the Gelfilm patch .
Delivering medication to the inner ear Th e surgeon deli vers the first dose of the prescribed medic ation onto the MicroWick with a 27-gauge, l .5-in needl e on a tubercul in syringe. The patient is then given a prescripti on for the medi cation to self-administer and instructions to return to the offic e weekly for evalu ation .
Meniere's disease. For patient s with Meniere' s disease, sterile techn iques are used in the pha rmacy to prepare a lO-ml dilute solution of gentamicin eardrops. Usually 10 mg/ml is prep ared and poured into a sterile dropp er bottle. A low er concentration (5 mg/ml ) is usually used when hea ring is better than 30 dB pure-tone avera ge.
The patient is instru cted to lie supine for 15 minutes with the head turn ed and then self-administer 3 drops of med ication into the ear canal three times a da y. At the end of each week, the pati ent return s to the office and hearin g is evaluated by audiometric testing of air , bone , and discrim ination , and ves tibular fun ction is te sted by bith erm al air and ice air electronystag mog raphy (ENG). Depend ing on the test result s and the patient' s symptoms, treatment is either continued or terminated. The goal of treatm ent is to obtain a 100% redu ced vestibular response to both bitherm al and ice air caloric ENG testin g without producing a loss of hearing.
The usual duration of treatment is I to 3 weeks. If hearin g has significa ntly diminished du ring treatment but vestibular function is still present , then the dose of gentam icin can be redu ced to 5 mg/ml or the treatment can be temp oraril y stopped. Retreatment with a low dose is possible after the hearing stabilizes . Gent amicin relieves attacks of Meni ere ' s disea se in 80% of cases." If the vertigo attac ks continue, the phy sician can perform either a posterior foss a vestibular neure ctomy or a labyrinth ectom y, depending on the level of hearing.
Sudden deafnes s and autoimmune inner ear disease.
A solution of dexam ethasone 24 mg/ml is prep ared at a pharmacy and put in a sterile dropp er bottl e. Best results are obtained when treatment is initiated as early as possible. Treatment is usuall y prescribed for no more than 4 weeks. The deci sion whether or not to pre scrib e oral 
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PATENT PENDING Crura of stapes the completion of treatment with the MicroWick. There have been two cases where the vent tube and wick extruded during treatment and needed to be replaced.
Discussion
The MicroWick device is simple and easy to use. The advantage of using the laser technique to make the opening in the tympanic membrane is that it makes a bloodless opening, thereby minimizing the chance of fluid coming into contact with the wick or endoscope. Any fluid that comes into contact with the MicroWick will cause it to swell immediately and will preclude proper placement in the round window niche. When blood or fluid in the area cannot be removed, the procedure can be terminated after the endoscopic view of the middle ear has been made and the vent tube has been inserted. The MicroWick can be placed several days to a week later, after the ear has dried .
The advantage of looking into the round window niche with the endoscope is that the surgeon can detect any obstructing membranes that may be present, which occurs in approximately 20% of the cases. ' The membranes can be removed with a small pick and the microscope. The round window membrane niche should be completely open to accept the MicroWick.
The MicroWick can still be placed if a laser and endo- 
Complications
There have been no cases of permanent tympanic membrane perforation or persistent infection that precluded prednisone prior to dexamethasone treatment rests with the individual physician. If the patient cannot tolerate high-dose steroids because of concomitant hypertension, diabetes, or ulcer, the physician can proceed directly with intratyrnpanic dexamethasone. If the patient can tolerate oral steroids, then it is up to the patient and the physician to decide which treatment will be tried first.
The patient should administer 3 drops three times daily and lie in the supine position with the head turned for 15 minutes after instilling the medication. In addition, antibiotic eardrops should be instilled once a day to prevent infection. Hearing is assessed after 2 weeks, at which time the physician should determine whether to continue or terminate treatment. scope are not available. Phenol or a tetr acaine-based . solution ca n be used to anesthetize the tympanic membrane, after which the vent tube ca n be inserted dire ctl y over the round window niche. The placement of the incision in the tympanic membrane is critical to the success ful insertion of the MicroWick into the round window niche. Usu ally the round window niche can be seen through a normal tympanic membrane as a dark shadow beneath the tympanic membrane. If the tympanic membrane has been scarred as a resu lt of a previous infection, determining the exact location beneath the tympanic membrane can be difficult. With the laser, a small opening can be made in the tymp anic membrane over the suspected site, and the loc ation of the 2-mm opening can be adjusted so that it is directly overthe round window niche. A vertical myrin gotomy posterior to the umbo will allow for the proper placement of the vent tube over the round window niche .
Cautions. Certain cautions need to be kept in mind when using the MicroWick technique. For example, occasionally the opening in the tympanic membrane will not be directly over the round wind ow niche. But even if this occurs, medication will still enter the middle ear and diffuse through the round window membrane. Also, when using a steroid to treat inner ear disease, antib iotic eardrops must be administered once a day to prevent middle ea r infecti on. Finally, pulling the MicroWick through an implanted vent tube may cause it to break off in the middle ear. Thi s will require injecting the ear with lidocaine and remov ing the remaining wick material.
But the advantages of this delivery system outweigh any potentia l drawbacks. For examp le, placement of the MicroWick is easy, safe, and inexpensive. Mor eover, self-treatment of inner ear disea se with otic medication is . well accepted by patients, and it obvi ates the neces sity for frequent return office visits. The medication can be kept in contact with the round window membrane for long periods, which is more efficient than administering blind injection s through the eardrum in the surgeon's offic e. Another advantage is that most of the medic ation is not lost down the eustachi an tube, which can occur whe n medicati on is injected blindl y into the middle ear. With self-administered gentamicin, vestibular function has been completely ablated (no response to ice air caloric testin g) in 55 % of cases, and hearing has been maint ained at pretre atment levels in 80%.14Bec ause most patients with Meniere' s disease ha ve a sensorineural hearing loss prior to treatment, a furth er hearing loss has not been a major complaint, especially when vertig o attack s have been relieved . Finally, the MicroWick can be safely left in place for 4 weeks. 600 In the futur e, new medi cations might be develop ed to treat cer tain types of sensorineural hearin g loss and to redu ce tinni tus. In such an eve ntuality, the Mic roWi ck would allow the pat ient to self-administer these drugs directl y to the inner ear.
